rethinkTHC Search
Menu
Study breakdown

Oral Fluid Testing Could Detect Sativex Use and Distinguish It From Smoked Cannabis

Randomized Controlled TrialModerate evidence
The takeaway

Oral fluid cannabinoid testing could distinguish between oral THC medication, Sativex spray, and smoked cannabis based on CBD/THC ratios and THCCOOH/THC ratios, enabling compliance monitoring and relapse detection.

Read this if you are prescribed a cannabinoid medication and are concerned about drug testing.

CBD/THC ratio of 0.82-1.34 in oral fluid specifically identified Sativex use

What the researchers found

Fourteen participants received oral THC (5 and 15 mg), low-dose Sativex, high-dose Sativex, and placebo in random order. After oral THC, oral fluid THC concentrations actually decreased over time (reflecting clearance of residual THC from prior smoked cannabis), with no measurable CBD or CBN.

After Sativex spray, THC, CBD, and CBN all increased dramatically, peaking within 15-60 minutes. The CBD/THC ratio was 0.82-1.34, reflecting Sativex's composition. THCCOOH/THC ratios within 4.5 hours post-Sativex were consistently below 1.6 pg/ng, always lower than after oral THC or placebo. These distinct patterns could identify Sativex compliance and distinguish it from smoked cannabis.

Why it matters

As medical cannabinoids become more common, the ability to monitor medication compliance and detect unauthorized cannabis use becomes important. This study established that oral fluid testing can distinguish between different cannabinoid products based on their unique metabolite patterns.

The numbers in context

14 participants. After Sativex: CBD/THC ratio 0.82-1.34. CBN/THC ratio 0.04-0.06. THCCOOH/THC <1.6 pg/ng within 4.5 hours. After oral THC: THC decreased over time, no CBD or CBN detected.

How the study worked

Randomized, placebo-controlled crossover study. 14 participants received 5 mg oral THC, 15 mg oral THC, low-dose Sativex (5.4 mg THC + 5.0 mg CBD), high-dose Sativex (16.2 mg THC + 15.0 mg CBD), and placebo. Oral fluid collected for 10.5 hours. Analyzed for THC, CBD, CBN, THCCOOH.

What this study cannot tell us

Small sample (14 participants). Oral fluid collection variability could affect results. The study participants had prior cannabis exposure, complicating baseline measurements. Real-world testing scenarios involve more variables than a controlled laboratory setting. The time window for detection varies.

How to read the evidence

Controlled crossover study with precise pharmacokinetic measurements; moderate evidence for clinical monitoring utility.

When this study was published

Published in 2013. Oral fluid cannabinoid testing has continued to develop for both clinical and forensic applications.

The bigger picture

This research addressed a practical clinical and forensic need: how to distinguish between legal medical cannabinoid use and illicit cannabis smoking. The pharmacokinetic profiles are sufficiently different to allow differentiation, supporting the development of monitoring protocols.

Questions still open

  • Could these markers be used in workplace drug testing to distinguish medical from recreational cannabis? How long after Sativex administration can compliance be confirmed? Would these patterns hold in chronic medical cannabis users?

Common questions

Can a drug test tell the difference between medical cannabis and smoked marijuana?
Yes, according to this study. Sativex (a medical THC/CBD spray) produces a distinctive pattern in oral fluid: high CBD/THC ratios (reflecting the equal CBD and THC content) and low THCCOOH/THC ratios shortly after use. Smoked cannabis and oral THC produce different patterns. However, this type of detailed analysis is not typically performed in standard workplace drug testing.
Can oral fluid detect if a patient is taking their cannabis medication as prescribed?
This study showed that Sativex produces measurable spikes in THC, CBD, and CBN in oral fluid within minutes of use, providing a way to confirm compliance. However, the window for detection is limited, and oral fluid is more useful for detecting recent use than for long-term compliance monitoring.

Read the original research

Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

Drug and alcohol dependence, 130(1-3), 68-76

Citation

Lee, Dayong; Karschner, Erin L; Milman, Garry; Barnes, Allan J; Goodwin, Robert S; Huestis, Marilyn A. (2013). Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?. Drug and alcohol dependence, 130(1-3), 68-76. https://doi.org/10.1016/j.drugalcdep.2012.10.011

Explore the wider topic